Professor in Virology at the Academic Medical Center University of Amsterdam IAS Paris 24 July 2017 Evaluation of lead HIV1 vaccine regimen in APPROACH Phase 12a study testing heterologous prime boost regimens using mosaic Ad26 and MVA vectors combined with Env protein ID: 724941
Download Presentation The PPT/PDF document "Hanneke Schuitemaker VP, Head Viral Vacc..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
